|
|
Exchange: |
N/A |
Security
Type: |
Common |
Shares
Out: |
152,980,000 |
Market
Cap: |
2.60(B) |
Last
Volume: |
0 |
Avg
Vol: |
0 |
52
Week Range: |
$12.12 - $19.58 |
|
Level
I Sector: |
N/A |
Level
II Sector: |
N/A |
Level
III Sector: |
N/A |
|
Member Indexes:
|
Rankings:
|
Insider 3 Months : - |
Insider 6 Months : - |
Insider 3/6 Months : - |
|
Guru Rank Number : - |
Guru Rank Value : - |
Guru Occurances : - |
|
|
|
|
|
|
|
Company Profile Certara is a holding company. Through its subsidiaries, Co. delivers software products and technology-enabled services to customers to realize the benefits of biosimulation in drug discovery, preclinincal and clinical research, regulatory submissions and market access. Co.'s End-to-End Platform provides software and technology-enabled services. Co. deploys its software to customers on public and private cloud networks, on-premises, and in data centers. Co.'s technology-enabled, biosimulation services help customers who do not have staff capability or availability to gain the benefits of biosimulation. Co. also provides related, technology-enabled services.
|
|
D/I:
|
|
|
D
is for direct shares.
I is
for indirect shares.
D/I
refers to the Direct or Indirect
shares traded vs. held. |
|
|
Forms:
|
|
|
A
Form 4 is a form filed
by an insider to indicate a change
in ownership.
A Form
3 is a form filed by
an insider to indicate an
initial ownership of a security. |
|
|
3m +/-:
|
|
|
This
represents the company's 3 month
price change. The initial price
is based on the closing price
of the stock on the day the transaction
took place. Purchases & sales
are viewed as long & short
positions respectively.
|
|
|
Actions:
|
|
|
B |
Buy |
S |
Sell |
OE |
Option
Exercised |
A |
Acquired |
D |
Disposed |
AB |
Automatic
Buy |
AS |
Automatic
Sell |
IO |
Initial
Ownership |
|
|
|
Download:
|
|
|
Download only Transactions
Forms. (Default)
Download
only Summary Infomation.
Download
both Transactions and Summary Data
|
|
|
|
|
|
|
Summary (Direct Transactions Only) |
3 Months |
6 Months |
12 Months |
24 Months |
Total Shares Bought |
0 |
0 |
5,000 |
50,000 |
Total Buy Value |
$0 |
$0 |
$79,058 |
$821,458 |
Total People Bought |
0 |
0 |
1 |
3 |
Total Buy Transactions |
0 |
0 |
2 |
4 |
Total Shares Sold |
17,427 |
37,427 |
88,651 |
36,609,838 |
Total Sell Value |
$297,161 |
$658,001 |
$1,405,871 |
$564,475,261 |
Total People Sold |
2 |
2 |
3 |
6 |
Total Sell Transactions |
2 |
6 |
7 |
21 |
End Date |
2024-03-10 |
2023-12-08 |
2023-06-09 |
2022-06-09 |
|
Filer's Name |
Relation Title |
Off-Dir-10% |
Tran. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
3m +/- |
|
|
Form |
Aspbury Robert |
PRESIDENT; SCIENTIFIC SOFTWARE |
|
2024-03-05 |
4 |
A |
$0.00 |
$0 |
D/D |
15,549 |
285,992 |
|
- |
|
Feehery William F |
CHIEF EXECUTIVE OFFICER |
|
2024-03-05 |
4 |
D |
$18.88 |
$331,476 |
D/D |
(17,557) |
2,221,984 |
|
- |
|
Feehery William F |
CHIEF EXECUTIVE OFFICER |
|
2024-03-05 |
4 |
A |
$0.00 |
$0 |
D/D |
59,799 |
2,239,541 |
|
- |
|
Traynor Richard M. |
SVP AND GENERAL COUNSEL |
|
2024-03-05 |
4 |
D |
$18.88 |
$69,101 |
D/D |
(3,660) |
169,473 |
|
- |
|
Traynor Richard M. |
SVP AND GENERAL COUNSEL |
|
2024-03-05 |
4 |
A |
$0.00 |
$0 |
D/D |
10,765 |
173,133 |
|
- |
|
Sherman Nicolette D |
CHIEF HUMAN RESOURCES OFFICER |
|
2024-03-05 |
4 |
D |
$18.88 |
$44,802 |
D/D |
(2,373) |
18,717 |
|
- |
|
Sherman Nicolette D |
CHIEF HUMAN RESOURCES OFFICER |
|
2024-03-05 |
4 |
A |
$0.00 |
$0 |
D/D |
6,600 |
21,090 |
|
- |
|
Traynor Richard M. |
SVP AND GENERAL COUNSEL |
|
2024-03-04 |
4 |
AS |
$18.28 |
$54,840 |
D/D |
(3,000) |
162,368 |
|
-10% |
|
Smith Patrick F |
PRESIDENT, DRUG DEV SOLUTIONS |
|
2024-02-20 |
4 |
AS |
$18.00 |
$90,000 |
D/D |
(5,000) |
54,975 |
|
-2% |
|
Traynor Richard M. |
SVP AND GENERAL COUNSEL |
|
2024-02-12 |
4 |
AS |
$18.00 |
$108,000 |
D/D |
(6,000) |
165,368 |
|
-5% |
|
Traynor Richard M. |
SVP AND GENERAL COUNSEL |
|
2023-12-26 |
4 |
AS |
$18.00 |
$108,000 |
D/D |
(6,000) |
171,368 |
|
-3% |
|
Pedersen Leif E |
PRESIDENT, CHIEF COMMERCAL OFF |
|
2023-09-11 |
4 |
AS |
$14.60 |
$747,870 |
D/D |
(51,224) |
128,883 |
|
11% |
|
Broshy Eran |
|
|
2023-08-22 |
4 |
B |
$15.80 |
$75,951 |
D/D |
4,807 |
14,360 |
0.01 |
12% |
|
Broshy Eran |
|
|
2023-08-21 |
4 |
B |
$16.10 |
$3,107 |
D/D |
193 |
9,553 |
0.01 |
11% |
|
Sherman Nicolette D |
CHIEF HUMAN RESOURCES OFFICER |
|
2023-08-01 |
4 |
D |
$19.47 |
$20,580 |
D/D |
(1,057) |
14,490 |
|
- |
|
Aspbury Robert |
PRESIDENT, SIMCYP |
|
2023-06-30 |
4 |
D |
$18.19 |
$15,680 |
D/D |
(862) |
276,065 |
|
- |
|
Smith Patrick F |
PRESIDENT, INTEGRATED DRUG DEV |
|
2023-06-05 |
4 |
AS |
$21.55 |
$411,691 |
D/D |
(19,104) |
59,975 |
|
-35% |
|
Broshy Eran |
|
|
2023-05-23 |
4 |
OE |
$0.00 |
$0 |
D/D |
9,360 |
9,360 |
|
- |
|
Crane Rosemary A |
|
|
2023-05-23 |
4 |
OE |
$0.00 |
$0 |
D/D |
9,324 |
9,324 |
|
- |
|
Walsh Matthew M |
|
|
2023-05-17 |
4 |
OE |
$0.00 |
$0 |
D/D |
9,067 |
176,968 |
|
- |
|
Collins Cynthia |
|
|
2023-05-17 |
4 |
OE |
$0.00 |
$0 |
D/D |
9,067 |
15,498 |
|
- |
|
Cashman James E III |
|
|
2023-05-17 |
4 |
OE |
$0.00 |
$0 |
D/D |
9,067 |
447,849 |
|
- |
|
Killefer Nancy |
|
|
2023-05-17 |
4 |
OE |
$0.00 |
$0 |
D/D |
9,067 |
15,498 |
|
- |
|
Traynor Richard M. |
SVP AND GENERAL COUNSEL |
|
2023-05-11 |
4 |
AS |
$20.82 |
$104,100 |
D/D |
(5,000) |
177,368 |
|
-32% |
|
Traynor Richard M. |
SVP AND GENERAL COUNSEL |
|
2023-04-14 |
4 |
AS |
$23.66 |
$118,300 |
D/D |
(5,000) |
182,368 |
|
-34% |
|
193 Records found
|
|
Page 2 of 8 |
|
|
|
Transaction Code Key: |
Ownership Code Key |
|
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
|
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Acquired |
|
IO |
- Initital Ownership |
D |
- Disposed |
|
|
|
|
|
|